ENCOMPASS HLTH Revenue Chart

Add to My Stocks
$53.04 $0.26 (0.49%) EHC stock closing price Feb 22, 2018 (Closing)
The latest 2017-Q3 ENCOMPASS HLTH revenue is 995.6M. Compare ENCOMPASS HLTH revenue chart with Quest Diagnostics revenue, DAVITA INC revenue.

EHC Revenue Chart

Quarterly Annual
  • Download
    • Download PNG image
    • Download JPEG image
    • Download SVG image
    • Download PDF document
Embed
Compare with
CHE revenue
DGX revenue
DVA revenue
EVHC revenue
You can do annual as well as quarterly comparisons of ENCOMPASS HLTH net sales with its competitor companies like Quest Diagnostics, DAVITA INC. Over the 5 year period ENCOMPASS HLTH revenue in 2016 was highest at 3.65B. In the latest quarter, EHC revenue 2017-Q3 has changed from 981.3M to 995.6M implying an increase of 1.46%.

ENCOMPASS HLTH Quarterly Revenue

* Past 5 years Range

Max EHC Revenue $995.6M Sep, 2017
Min EHC Revenue $552.9M Dec, 2012

ENCOMPASS HLTH Annual Revenue

* Past 5 years Range

Max EHC Revenue $3.65B Dec, 2016
Min EHC Revenue $2.13B Dec, 2012

ENCOMPASS HLTH Annual Revenue VS Peers

2016 2015 2014 2013 2012
ENCOMPASS HLTH Revenue $3.65B$3.12B$2.37B$2.25B$2.13B
Quest Diagnostics Revenue $7.52B$7.49B$7.44B$7.15B$7.38B
DAVITA INC Revenue $14.75B$13.78B$12.8B$11.76B$8.19B
ENVISION HLTHCR Revenue $3.7B$2.57B$1.62B$1.08B$928.5M
Chemed Revenue $1.58B$1.54B$1.46B$1.41B$1.43B
MyoKardia Revenue $39.19M$14.19M$5.91M--------